Global Narcotic (Opioid) Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4813497
- 102 Pages
- February 2022
- Pharmaceuticals
The United States Narcotic (Opioid) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Narcotic (Opioid) Drugs market, reaching US$ million by the year 2028. As for the Europe Narcotic (Opioid) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Narcotic (Opioid) Drugs players cover Pfizer, Teva, Purdue Pharma, and Mallinckrodt, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Narcotic (Opioid) Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pain Relief Application
Anesthesia Application
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Narcotic (Opioid) Drugs Market Size 2017-2028
2.1.2 Narcotic (Opioid) Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Narcotic (Opioid) Drugs Segment by Type
2.2.1 Codeine
2.2.2 Fentanyl
2.2.3 Hydrocodone
2.2.4 Hydromorphone
2.2.5 Meperidine
2.2.6 Methadone
2.2.7 Others
2.3 Narcotic (Opioid) Drugs Market Size by Type
2.3.1 Narcotic (Opioid) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2022)
2.4 Narcotic (Opioid) Drugs Segment by Application
2.4.1 Pain Relief Application
2.4.2 Anesthesia Application
2.5 Narcotic (Opioid) Drugs Market Size by Application
2.5.1 Narcotic (Opioid) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2022)
3 Narcotic (Opioid) Drugs Market Size by Player
3.1 Narcotic (Opioid) Drugs Market Size Market Share by Players
3.1.1 Global Narcotic (Opioid) Drugs Revenue by Players (2020-2022)
3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Narcotic (Opioid) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Narcotic (Opioid) Drugs by Regions
4.1 Narcotic (Opioid) Drugs Market Size by Regions (2017-2022)
4.2 Americas Narcotic (Opioid) Drugs Market Size Growth (2017-2022)
4.3 APAC Narcotic (Opioid) Drugs Market Size Growth (2017-2022)
4.4 Europe Narcotic (Opioid) Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Narcotic (Opioid) Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
5.2 Americas Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
5.3 Americas Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Narcotic (Opioid) Drugs Market Size by Region (2017-2022)
6.2 APAC Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
6.3 APAC Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Narcotic (Opioid) Drugs by Country (2017-2022)
7.2 Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
7.3 Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Narcotic (Opioid) Drugs by Region (2017-2022)
8.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Narcotic (Opioid) Drugs Market Forecast
10.1 Global Narcotic (Opioid) Drugs Forecast by Regions (2023-2028)
10.1.1 Global Narcotic (Opioid) Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Narcotic (Opioid) Drugs Forecast
10.1.3 APAC Narcotic (Opioid) Drugs Forecast
10.1.4 Europe Narcotic (Opioid) Drugs Forecast
10.1.5 Middle East & Africa Narcotic (Opioid) Drugs Forecast
10.2 Americas Narcotic (Opioid) Drugs Forecast by Country (2023-2028)
10.2.1 United States Narcotic (Opioid) Drugs Market Forecast
10.2.2 Canada Narcotic (Opioid) Drugs Market Forecast
10.2.3 Mexico Narcotic (Opioid) Drugs Market Forecast
10.2.4 Brazil Narcotic (Opioid) Drugs Market Forecast
10.3 APAC Narcotic (Opioid) Drugs Forecast by Region (2023-2028)
10.3.1 China Narcotic (Opioid) Drugs Market Forecast
10.3.2 Japan Narcotic (Opioid) Drugs Market Forecast
10.3.3 Korea Narcotic (Opioid) Drugs Market Forecast
10.3.4 Southeast Asia Narcotic (Opioid) Drugs Market Forecast
10.3.5 India Narcotic (Opioid) Drugs Market Forecast
10.3.6 Australia Narcotic (Opioid) Drugs Market Forecast
10.4 Europe Narcotic (Opioid) Drugs Forecast by Country (2023-2028)
10.4.1 Germany Narcotic (Opioid) Drugs Market Forecast
10.4.2 France Narcotic (Opioid) Drugs Market Forecast
10.4.3 UK Narcotic (Opioid) Drugs Market Forecast
10.4.4 Italy Narcotic (Opioid) Drugs Market Forecast
10.4.5 Russia Narcotic (Opioid) Drugs Market Forecast
10.5 Middle East & Africa Narcotic (Opioid) Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Narcotic (Opioid) Drugs Market Forecast
10.5.2 South Africa Narcotic (Opioid) Drugs Market Forecast
10.5.3 Israel Narcotic (Opioid) Drugs Market Forecast
10.5.4 Turkey Narcotic (Opioid) Drugs Market Forecast
10.5.5 GCC Countries Narcotic (Opioid) Drugs Market Forecast
10.6 Global Narcotic (Opioid) Drugs Forecast by Type (2023-2028)
10.7 Global Narcotic (Opioid) Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Narcotic (Opioid) Drugs Product Offered
11.1.3 Pfizer Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Narcotic (Opioid) Drugs Product Offered
11.2.3 Teva Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Information
11.3.2 Purdue Pharma Narcotic (Opioid) Drugs Product Offered
11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Purdue Pharma Main Business Overview
11.3.5 Purdue Pharma Latest Developments
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Information
11.4.2 Mallinckrodt Narcotic (Opioid) Drugs Product Offered
11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Mallinckrodt Main Business Overview
11.4.5 Mallinckrodt Latest Developments
11.5 Amneal Pharma
11.5.1 Amneal Pharma Company Information
11.5.2 Amneal Pharma Narcotic (Opioid) Drugs Product Offered
11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Amneal Pharma Main Business Overview
11.5.5 Amneal Pharma Latest Developments
11.6 Collegium
11.6.1 Collegium Company Information
11.6.2 Collegium Narcotic (Opioid) Drugs Product Offered
11.6.3 Collegium Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Collegium Main Business Overview
11.6.5 Collegium Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Narcotic (Opioid) Drugs Product Offered
11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Narcotic (Opioid) Drugs Product Offered
11.8.3 Merck Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Narcotic (Opioid) Drugs Product Offered
11.9.3 Mylan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Information
11.10.2 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Offered
11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Hikma Pharmaceuticals Main Business Overview
11.10.5 Hikma Pharmaceuticals Latest Developments
11.11 Sun Pharma
11.11.1 Sun Pharma Company Information
11.11.2 Sun Pharma Narcotic (Opioid) Drugs Product Offered
11.11.3 Sun Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sun Pharma Main Business Overview
11.11.5 Sun Pharma Latest Developments
11.12 Endo Pharmaceuticals
11.12.1 Endo Pharmaceuticals Company Information
11.12.2 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Offered
11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Endo Pharmaceuticals Main Business Overview
11.12.5 Endo Pharmaceuticals Latest Developments
11.13 Allergan
11.13.1 Allergan Company Information
11.13.2 Allergan Narcotic (Opioid) Drugs Product Offered
11.13.3 Allergan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Allergan Main Business Overview
11.13.5 Allergan Latest Developments
12 Research Findings and Conclusion
Table 1. Narcotic (Opioid) Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Codeine
Table 3. Major Players of Fentanyl
Table 4. Major Players of Hydrocodone
Table 5. Major Players of Hydromorphone
Table 6. Major Players of Meperidine
Table 7. Major Players of Methadone
Table 8. Major Players of Others
Table 9. Narcotic (Opioid) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2022)
Table 12. Narcotic (Opioid) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2022)
Table 15. Global Narcotic (Opioid) Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Narcotic (Opioid) Drugs Revenue Market Share by Player (2020-2022)
Table 17. Narcotic (Opioid) Drugs Key Players Head office and Products Offered
Table 18. Narcotic (Opioid) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Narcotic (Opioid) Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Narcotic (Opioid) Drugs Market Size Market Share by Regions (2017-2022)
Table 23. Americas Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Narcotic (Opioid) Drugs Market Size Market Share by Country (2017-2022)
Table 25. Americas Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2022)
Table 27. Americas Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2022)
Table 29. APAC Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Narcotic (Opioid) Drugs Market Size Market Share by Region (2017-2022)
Table 31. APAC Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2022)
Table 33. APAC Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2022)
Table 35. Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Narcotic (Opioid) Drugs Market Size Market Share by Country (2017-2022)
Table 37. Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2022)
Table 39. Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Narcotic (Opioid) Drugs Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Narcotic (Opioid) Drugs
Table 48. Key Market Challenges & Risks of Narcotic (Opioid) Drugs
Table 49. Key Industry Trends of Narcotic (Opioid) Drugs
Table 50. Global Narcotic (Opioid) Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Narcotic (Opioid) Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Narcotic (Opioid) Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Narcotic (Opioid) Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Narcotic (Opioid) Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Narcotic (Opioid) Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 56. Pfizer Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 57. Pfizer Narcotic (Opioid) Drugs Product Offered
Table 58. Pfizer Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Teva Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 62. Teva Narcotic (Opioid) Drugs Product Offered
Table 63. Teva Main Business
Table 64. Teva Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Teva Latest Developments
Table 66. Purdue Pharma Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 67. Purdue Pharma Narcotic (Opioid) Drugs Product Offered
Table 68. Purdue Pharma Main Business
Table 69. Purdue Pharma Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Purdue Pharma Latest Developments
Table 71. Mallinckrodt Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 72. Mallinckrodt Narcotic (Opioid) Drugs Product Offered
Table 73. Mallinckrodt Main Business
Table 74. Mallinckrodt Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Mallinckrodt Latest Developments
Table 76. Amneal Pharma Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 77. Amneal Pharma Narcotic (Opioid) Drugs Product Offered
Table 78. Amneal Pharma Main Business
Table 79. Amneal Pharma Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Amneal Pharma Latest Developments
Table 81. Collegium Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 82. Collegium Narcotic (Opioid) Drugs Product Offered
Table 83. Collegium Main Business
Table 84. Collegium Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Collegium Latest Developments
Table 86. Johnson & Johnson Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 87. Johnson & Johnson Narcotic (Opioid) Drugs Product Offered
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Johnson & Johnson Latest Developments
Table 91. Merck Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 92. Merck Narcotic (Opioid) Drugs Product Offered
Table 93. Merck Main Business
Table 94. Merck Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Merck Latest Developments
Table 96. Mylan Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 97. Mylan Narcotic (Opioid) Drugs Product Offered
Table 98. Mylan Main Business
Table 99. Mylan Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Mylan Latest Developments
Table 101. Hikma Pharmaceuticals Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 102. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Offered
Table 103. Hikma Pharmaceuticals Main Business
Table 104. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Hikma Pharmaceuticals Latest Developments
Table 106. Sun Pharma Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 107. Sun Pharma Narcotic (Opioid) Drugs Product Offered
Table 108. Sun Pharma Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Sun Pharma Main Business
Table 110. Sun Pharma Latest Developments
Table 111. Endo Pharmaceuticals Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 112. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Offered
Table 113. Endo Pharmaceuticals Main Business
Table 114. Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Endo Pharmaceuticals Latest Developments
Table 116. Allergan Details, Company Type, Narcotic (Opioid) Drugs Area Served and Its Competitors
Table 117. Allergan Narcotic (Opioid) Drugs Product Offered
Table 118. Allergan Main Business
Table 119. Allergan Narcotic (Opioid) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Allergan Latest Developments
List of Figures
Figure 1. Narcotic (Opioid) Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Narcotic (Opioid) Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Narcotic (Opioid) Drugs Market Size Market Share by Type in 2021
Figure 7. Narcotic (Opioid) Drugs in Pain Relief Application
Figure 8. Global Narcotic (Opioid) Drugs Market: Pain Relief Application (2017-2022) & ($ Millions)
Figure 9. Narcotic (Opioid) Drugs in Anesthesia Application
Figure 10. Global Narcotic (Opioid) Drugs Market: Anesthesia Application (2017-2022) & ($ Millions)
Figure 11. Global Narcotic (Opioid) Drugs Market Size Market Share by Application in 2021
Figure 12. Global Narcotic (Opioid) Drugs Revenue Market Share by Player in 2021
Figure 13. Global Narcotic (Opioid) Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Narcotic (Opioid) Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Narcotic (Opioid) Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Narcotic (Opioid) Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Narcotic (Opioid) Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Narcotic (Opioid) Drugs Value Market Share by Country in 2021
Figure 19. Americas Narcotic (Opioid) Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Narcotic (Opioid) Drugs Market Size Market Share by Application in 2021
Figure 21. United States Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Narcotic (Opioid) Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Narcotic (Opioid) Drugs Market Size Market Share by Application in 2021
Figure 27. China Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Narcotic (Opioid) Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Narcotic (Opioid) Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Narcotic (Opioid) Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Narcotic (Opioid) Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Narcotic (Opioid) Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Narcotic (Opioid) Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Narcotic (Opioid) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Narcotic (Opioid) Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
